National Pension Service Has $53.26 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

National Pension Service lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 4.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 681,302 shares of the company's stock after selling 34,700 shares during the period. National Pension Service owned 0.15% of GE HealthCare Technologies worth $53,264,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in GEHC. Cherry Creek Investment Advisors Inc. increased its holdings in shares of GE HealthCare Technologies by 0.3% in the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock valued at $2,920,000 after purchasing an additional 114 shares during the period. Independence Bank of Kentucky grew its position in GE HealthCare Technologies by 6.0% during the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock valued at $158,000 after acquiring an additional 114 shares during the period. Tandem Capital Management Corp ADV increased its holdings in GE HealthCare Technologies by 0.4% in the 4th quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock valued at $2,205,000 after purchasing an additional 118 shares in the last quarter. Arcus Capital Partners LLC grew its stake in shares of GE HealthCare Technologies by 3.0% during the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock valued at $322,000 after acquiring an additional 119 shares in the last quarter. Finally, Custom Index Systems LLC raised its stake in GE HealthCare Technologies by 4.4% during the fourth quarter. Custom Index Systems LLC now owns 2,843 shares of the company's stock worth $222,000 after acquiring an additional 120 shares during the period. Institutional investors and hedge funds own 82.06% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

GEHC has been the topic of several recent analyst reports. Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Wells Fargo & Company lifted their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and a consensus target price of $97.67.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC traded down $0.90 during midday trading on Monday, reaching $86.45. The company's stock had a trading volume of 3,532,230 shares, compared to its average volume of 2,903,375. The business's fifty day simple moving average is $86.17 and its 200-day simple moving average is $86.14. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a market capitalization of $39.53 billion, a P/E ratio of 19.97, a P/E/G ratio of 3.19 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.